Second round of funding from existing investors will further drive company expansion and commercial growth of its AI-enabled drug discovery technology CAMBRIDGE, UK: Optibrium™, a developer of software for drug discovery, today announced it has secured further investment from existing investors Kester Capital, a leading UK mid-market private equity firm. Typically investing in high potential, innovative […]
Investment in new headquarters forms part of ongoing company growth plans The new facility supports the continued success of Optibrium’s drug discovery technologies and accommodates an expanding team CAMBRIDGE, UK: Optibrium™, a developer of software for drug discovery, today announced the expansion of its UK headquarters with a move to larger office premises on Cambridge Innovation […]
PRINCETON, N.J. — Certara, Inc., a global leader in biosimulation, and Chemaxon, a leading chemical and biological software development company, today announced a strategic partnership to accelerate drug discovery research through integrated scientific informatic workflows to modernize pharmaceutical research. This partnership provides interconnectivity between Certara’s D360 Scientific Informatics software and Chemaxon’s Design Hub to deliver a seamless user workflow […]
Cambridge, UK – Cresset Discovery, provider of CADD expertise for drug discovery, is collaborating with the Translation team at The Francis Crick Institute as expert computational chemist in residence. Computational chemistry is a powerful method in tool development and drug discovery. It enables chemists to predict the physical properties and biological activity of compounds prior to synthesis […]
SANTA FE, N.M., and WALLINGFORD, Conn. – OpenEye Scientific and Gaussian – both of which are leading computational chemistry software companies – today announced that OpenEye’s Orion® molecular design platform now is supporting Gaussian and its electronic-structure modeling software with automated scientific workflows to facilitate more rapid and comprehensive quantum chemistry calculations. The Orion® Gaussian Module will […]
Ability to import 3D molecular models with one click accelerates information sharing, collaboration and decision making WALTHAM, Mass. – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced V21 of its ChemDraw® software featuring the ability to import, animate and share 3D chemical structures natively in the Microsoft® PowerPoint® application with one […]
New Inspyra module combines chemists’ expertise with exploratory capabilities of automated compound design Inspyra provides drug designers direct access to powerful AI capabilities, supporting established workflow CAMBRIDGE, UK: Optibrium Ltd, a leading developer of software for drug discovery, today announced the release of the latest version of StarDrop™, its comprehensive software platform for small molecule design, […]
Globachem renews contract with Cresset Discovery Cambridge, UK – Cresset Discovery, provider of contract consulting for early phase discovery, has been appointed by Globachem, who specialize in developing and marketing high quality crop protection products, to upskill their in-house team and assist them in developing the next generation of novel agrochemicals. Agrochemicals, which include pesticides and fertilizers, facilitate higher yields […]
Chemaxon, a leader in cheminformatics software development for life science research, announced the appointment of Richard Jones as Chief Executive Officer (CEO). Richard follows owner Ferenc (Csizi) Csizmadia in the position. “Chemaxon has a great reputation globally. Following on from my work in Lab of the Future, I am excited about the opportunity to take […]
Discngine, a research and lab informatics software and services company, announces a strategic partnership with ChemAxon, a leading cheminformatics and bioinformatics company. By joining forces, the partners expect to streamline pharma and biotech research involving complex biomolecular structural data. Paris —Discngine’s 3decision platform stores, categorizes and analyzes protein-ligand structural data in a centralized knowledge base. Its fundamental value […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
